» Articles » PMID: 27408213

Serum Serotonin Abnormality in Depression

Overview
Specialty General Medicine
Date 2016 Jul 14
PMID 27408213
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Serotonin plays an important role in treatment of depression. We evaluated the clinical correlates of plasma serotonin levels in depressed patients before and after treatment.

Methods: Study sample comprised of 40 patients diagnosed on ICD-10 diagnostic criteria, and an equal number of healthy matched controls. Subjects were evaluated on Beck's Depression Inventory (BDI) and Suicide Ideation Scale (SIS), before and after the treatment. Blood samples were collected from all the cases and controls before starting the antidepressant medication with selective serotonin reuptake inhibitors (SSRI's). Serum serotonin levels were measured before and after treatment.

Result: Significant differences in scores before and after the intervention on BDI, SIS and serotonin levels of cases and controls (p<.000) were noted. Correlation between the serum serotonin levels before and after the treatment, and between the rating scales did not reveal significant association (p > 0.05). Patients with suicidal intentions had lower levels of serotonin. The scores changed after intervention.

Conclusion: Treatment with SSRI's had shown significant changes in clinical conditions. However these changes did not relate significantly with serum serotonin levels.

Citing Articles

Depression Paradox in Cardiovascular Outcomes of Adult Patients with Obstructive Sleep Apnea: Insights from 2 Million Nationwide Hospitalizations.

Desai R, Srikanth S, Chauhan S, Gandhi Z, Shahnawaz W, Rahman A Thorac Res Pract. 2025; 26(2):43-47.

PMID: 39930796 PMC: 11796293. DOI: 10.4274/ThoracResPract.2024.23132.


Higher serotonin levels among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis compared to healthy controls assessed by liquid chromatography-tandem mass spectrometry (LC-MS).

Gula Z, Krzysciak W, Kuszmiersz P, Bystrowska B, Korkosz M Rheumatol Int. 2025; 45(1):17.

PMID: 39751835 DOI: 10.1007/s00296-024-05769-0.


Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model.

Bhoj P, Nocito C, Togre N, Winfield M, Lubinsky C, Khan S Int J Mol Sci. 2024; 25(18).

PMID: 39337564 PMC: 11432477. DOI: 10.3390/ijms251810080.


Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.

Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S Nutrients. 2024; 16(15).

PMID: 39125295 PMC: 11314607. DOI: 10.3390/nu16152414.


Serotonin Levels in Newly-Infected HIV-Positive: A Preliminary Study.

Tahir M, Agus Mumang A, Kadar K, Mubin R, Hamid F Med Arch. 2024; 78(1):55-59.

PMID: 38481592 PMC: 10928688. DOI: 10.5455/medarh.2024.78.55-59.


References
1.
Roggenbach J, Muller-Oerlinghausen B, Franke L . Suicidality, impulsivity and aggression--is there a link to 5HIAA concentration in the cerebrospinal fluid?. Psychiatry Res. 2002; 113(1-2):193-206. DOI: 10.1016/s0165-1781(02)00230-5. View

2.
Beck A, Kovacs M, Weissman A . Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979; 47(2):343-52. DOI: 10.1037//0022-006x.47.2.343. View

3.
Schloss P, Williams D . The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol. 1998; 12(2):115-21. DOI: 10.1177/026988119801200201. View

4.
Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

5.
Mann J, McBride P, Anderson G, Mieczkowski T . Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry. 1992; 32(3):243-57. DOI: 10.1016/0006-3223(92)90106-a. View